Ignite Creation Date:
2025-12-24 @ 4:46 PM
Ignite Modification Date:
2026-01-04 @ 2:53 AM
Study NCT ID:
NCT02500550
Status:
COMPLETED
Last Update Posted:
2021-05-18
First Post:
2015-07-14
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Safety and Efficacy of Two Doses of ATIR101, a T-lymphocyte Enriched Leukocyte Preparation Depleted of Host Alloreactive T-cells, in Patients With a Hematologic Malignancy Who Received a Hematopoietic Stem Cell Transplantation From a Haploidentical Donor
Sponsor:
Kiadis Pharma
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2015-10-09
Start Date Type:
ACTUAL
Primary Completion Date:
2018-07
Primary Completion Date Type:
ACTUAL
Completion Date:
2018-12-17
Completion Date Type:
ACTUAL
First Submit Date:
2015-07-14
First Submit QC Date:
None
Study First Post Date:
2015-07-16
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2020-12-17
Results First Submit QC Date:
None
Results First Post Date:
2021-01-12
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
2019-08-20
Disp First Post Date Type:
ACTUAL
Last Update Submit Date:
2021-05-17
Last Update Post Date:
2021-05-18
Last Update Post Date Type:
ACTUAL